Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
American Journal of Hypertension|November 3, 1998
Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?S Jacob, K Rett, E J Henriksen
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|August 1, 1980
Insulin-like activity of bradykinin on amino acid balances across the human forearmR Schifman, M Wicklmayr, I Boettger, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 1, 1983
Substrate balances across the forearm during the early postoperative periodB Günther, M Wicklmayr, W Hartl, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitusM Füchtenbusch, E Standl, H Schatz
Diabetes, Obesity & Metabolism|October 11, 2007
Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapyO Schnell, G Mertes, E Standl, et al.
Studies in Health Technology and Informatics|February 24, 2001
Telecare of diabetic patients with intensified insulin therapy. A randomized clinical trialE Biermann, W Dietrich, E Standl
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 24, 2007
Chromium in metabolic and cardiovascular diseaseM Hummel, E Standl, O Schnell
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|March 1, 1993
[Macroangiopathy in diabetes mellitus]H Stiegler, E Standl, V Hufen
Metabolism: Clinical and Experimental|August 1, 1978
An adverse effect of insulin on the oxygen-release capacity of red blood cells in nonacidotic diabeticsJ Ditzel, P Jaeger, E Standl
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 5, 2006
Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibilityE Standl, S Maxeiner, S Raptis, et al.
Pageof 20